Current status and perspectives of therapy for acute myeloid leukemia-Reference-Cited by-同舟云学术

Current status and perspectives of therapy for acute myeloid leukemia

Published:2001-07 Issue: Volume:38 Page:3-9
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Hiddemann Wolfgang,Büchner Thomas

Publisher

Elsevier BV

Subject

Hematology

Reference18 articles.

1. Acute myeloid leukemia;Löwenberg;N Engl J Med,1999

2. Tailoring the treatment of acute leukemia;Burnett;Curr Opin Hematol,1999

3. Four decades of therapy for AML;Freireich;Leukemia,1998

4. Frequency of prolonged remission duration after highdose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype;Bloomfield;Cancer Res,1998

5. Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: Relevance of cytogenetic abnormalities;Kern;Leukemia,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid In-vitro Testing for Chemotherapy Sensitivity in Leukaemia Patients;Advances in Biochemical Engineering/Biotechnology;2014

2. Biosensors in Clinical Practice: Focus on Oncohematology;Sensors;2013-05-14

3. Serine protease (TPS): A diagnostic and prognostic marker in pediatric patients with acute non-lymphoblastic leukemia;Egyptian Journal of Medical Human Genetics;2011-11

4. A Bioluminescent Microbial Biosensor for In Vitro Pretreatment Assessment of Cytarabine Efficacy in Leukemia;Clinical Chemistry;2010-12-01

5. Aktuelle Tumorpathologie;Der Pathologe;2010-01-13